JPRN-C000000112
Unknown
未知
Phase II study of carboplatin-gemcitabine combination chemotherapy in elderly patients with advanced non–small cell lung cancer - Phase II study of carboplatin-gemcitabine combination chemotherapy in elderly patients with advanced non–small cell lung cancer
Kumamoto University School of Medicine0 sites55 target enrollmentSeptember 4, 2005
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Kumamoto University School of Medicine
- Enrollment
- 55
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Individuals with active infection, severe heart disease, active concomitant malignancy, or pleural or pericardial effusion requiring drainage were excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urotheliumISRCTN88259320School of Medicine, Zhejiang University (China)39
Not yet recruiting
Not Applicable
Phase I study of gemcitabine and carboplatin plus sorafenib in patients with advanced solid tumorsadvanced solid tumorsCancer10027655NL-OMON31053Antoni van Leeuwenhoek Ziekenhuis28
Completed
Not Applicable
A phase II study combining gemcitabine and carboplatin in patients with platinum-resistant ovarian cancerpatients with platinum-resistant ovarian cancerJPRN-UMIN000019225Osaka medical coledge30
Completed
Not Applicable
Randomized phase II study of carboplatin / gemcitabine versus vinorelbine / gemcitabine in patients with advanced non-small cell lung cancerStage IIIb/IV NSCLCJPRN-C000000110West Japan Oncology Group120
Active, not recruiting
Phase 2
GHG-GCDrelapsed or refractory non-Hodgkin's lymphomaJPRN-jRCT1041230085Tsurumi Hisashi20